Profile data is unavailable for this security.
About the company
Cyclopharm Limited is an Australia-based radiopharmaceutical company. The Company's principal activity is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector. Its segments include Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and a distributor of products to the diagnostic imaging sector. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The Company uses Technegas technology, which is a structured ultra-fine dispersion of radioactive labelled carbon, produced by using driedTechnetium-99m in a carbon crucible. The Company distributes its products in approximately 65 countries.
- Revenue in AUD (TTM)32.21m
- Net income in AUD-4.70m
- Incorporated2005
- Employees87.00
- LocationCyclopharm LtdUnit 4 / 1 The Crescent, KingsgroveSYDNEY 2208AustraliaAUS
- Phone+61 29541-0411
- Fax+61 29543-0960
- Websitehttps://www.cyclopharm.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SDI Ltd | 109.61m | 8.04m | 108.17m | 300.00 | 13.45 | 1.21 | 8.76 | 0.9869 | 0.0676 | 0.0676 | 0.9221 | 0.7494 | 0.8449 | 1.69 | 6.22 | -- | 6.20 | 7.27 | 7.46 | 8.40 | 59.28 | 59.79 | 7.34 | 8.07 | 1.26 | 10.37 | 0.2318 | 51.85 | 13.35 | 7.67 | -3.09 | 4.50 | 52.58 | 5.39 |
| Imricor Medical Systems Inc | 941.53k | -34.61m | 117.66m | -- | -- | -- | -- | 124.97 | -0.2199 | -0.2199 | 0.006 | -0.0793 | 0.0559 | 0.8749 | 2.38 | -- | -205.60 | -93.47 | -294.49 | -106.30 | -181.27 | -134.71 | -3,675.60 | -2,462.89 | 0.4944 | -3.64 | 15.92 | -- | -24.56 | -9.29 | -30.36 | -- | -10.82 | -- |
| ImpediMed Ltd | 10.47m | -19.42m | 133.52m | 76.00 | -- | 2.62 | -- | 12.75 | -0.0102 | -0.0102 | 0.0055 | 0.0252 | 0.1961 | 1.32 | 4.41 | 137,802.60 | -36.37 | -52.27 | -40.94 | -62.34 | 86.95 | 80.64 | -185.47 | -264.76 | 6.85 | -- | 0.0244 | -- | 7.36 | 27.87 | -3.26 | -- | 37.83 | -- |
| Mach7 Technologies Ltd | 26.97m | -5.55m | 143.54m | 90.00 | -- | 2.64 | 66.32 | 5.32 | -0.0231 | -0.0231 | 0.1123 | 0.2256 | 0.3605 | -- | 3.21 | -- | -7.42 | -7.48 | -8.73 | -8.65 | 95.09 | 93.72 | -20.59 | -20.56 | -- | -2,605.17 | 0.0193 | -- | 10.97 | 28.30 | 74.85 | -- | 29.28 | -- |
| Genetic Signatures Ltd | 16.49m | -18.04m | 169.93m | -- | -- | 3.45 | -- | 10.30 | -0.1245 | -0.1245 | 0.1136 | 0.2172 | 0.3366 | 1.06 | 5.25 | -- | -36.81 | -7.14 | -40.19 | -7.82 | 40.66 | 57.68 | -109.38 | -13.74 | 5.95 | -18,040.00 | 0.0003 | -- | -38.11 | 33.44 | -558.77 | -- | 73.20 | -- |
| EMvision Medical Devices Ltd | 8.86m | -3.22m | 170.00m | -- | -- | 27.17 | -- | 19.19 | -0.0449 | -0.0449 | 0.1186 | 0.0733 | 0.7954 | -- | -- | -- | -28.95 | -67.20 | -45.25 | -79.38 | -- | -- | -36.40 | -175.99 | -- | -35.20 | 0.3424 | -- | 62.08 | 70.47 | 36.64 | -- | -- | -- |
| Cyclopharm Limited | 32.21m | -4.70m | 177.82m | 87.00 | -- | 4.67 | -- | 5.52 | -0.0508 | -0.0508 | 0.3476 | 0.3428 | 0.6748 | 1.11 | 4.13 | 370,173.10 | -9.85 | -12.60 | -11.92 | -14.94 | 68.15 | 70.20 | -14.60 | -25.47 | 2.32 | -18.40 | 0.1159 | -- | 11.22 | 15.50 | 28.90 | -- | -7.83 | -12.94 |
| Optiscan Imaging Ltd | 1.68m | -5.44m | 179.60m | 8.00 | -- | 10.96 | -- | 106.90 | -0.0074 | -0.0074 | 0.0023 | 0.0196 | 0.1344 | -0.5253 | 1.48 | -- | -43.54 | -47.55 | -50.01 | -57.08 | 148.55 | 5.08 | -323.87 | -254.44 | 9.43 | -- | 0.0269 | -- | 65.86 | -5.23 | -2.80 | -- | -15.27 | -- |
| 4DMedical Ltd | 1.03m | -30.83m | 211.42m | -- | -- | 2.21 | -- | 206.22 | -0.0882 | -0.0882 | 0.0029 | 0.2332 | 0.0098 | 0.092 | 0.1585 | -- | -29.47 | -43.96 | -39.07 | -57.58 | 95.00 | 32.30 | -3,007.64 | -2,704.36 | 1.79 | -- | 0.0476 | -- | -31.84 | -1.86 | -27.92 | -- | 2.46 | -- |
| Aroa Biosurgery Ltd | 62.18m | -9.57m | 216.85m | 261.00 | -- | 2.54 | -- | 3.49 | -0.0278 | -0.0278 | 0.1808 | 0.2483 | 0.607 | 1.56 | 2.82 | -- | -9.34 | -10.37 | -10.11 | -12.52 | 85.39 | 80.63 | -15.39 | -20.31 | 6.40 | -- | 0.0726 | -- | 9.01 | 24.26 | -2,583.84 | -- | 33.65 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Regal Funds Management Pty Ltd.as of 30 May 2024 | 12.00m | 11.09% |
| Investors Mutual Ltd.as of 28 Jun 2024 | 3.09m | 2.85% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.81m | 1.67% |
| Karst Peak Capital Ltd.as of 23 Apr 2024 | 0.00 | 0.00% |
